Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA.
Deeann WallisKairong LiHui LuiKe HuMei-Jan ChenJing LiJungsoon KangShamik DasBruce R KorfRobert A KestersonPublished in: Human mutation (2018)
Neurofibromatosis type 1 (NF1) is caused by pathogenic variants or mutations in the NF1 gene that encodes neurofibromin. We describe here a new approach to determining the functional consequences of NF1 genetic variants. We established a heterologous cell culture expression system using a full-length mouse Nf1 cDNA (mNf1) and human cell lines. We demonstrate that the full-length murine cDNA produces a > 250 kDa neurofibromin protein that is capable of modulating Ras signaling. We created mutant cDNAs representing NF1 patient variants with different clinically relevant phenotypes, and assessed their ability to produce mature neurofibromin and restore Nf1 activity in NF1-/- cells. These cDNAs represent variants in multiple protein domains and various types of clinically relevant predicted variants. This approach will help advance research on neurofibromin structure and function, determine pathogenicity for missense variants, and allow for the development of activity assays and variant-directed therapeutics.
Keyphrases
- signaling pathway
- lps induced
- copy number
- pi k akt
- nuclear factor
- oxidative stress
- induced apoptosis
- inflammatory response
- endothelial cells
- poor prognosis
- small molecule
- escherichia coli
- genome wide
- single cell
- cell death
- high throughput
- cell proliferation
- immune response
- transcription factor
- saccharomyces cerevisiae